SP Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

SP Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,667	Closed	-$442K	–	115
2022 Q4	$442K	Hold	15,667	–	–	0.06%	88
2022 Q3	$515K	Sell	15,667 -2,425	-13%	-$89K	0.07%	84
2022 Q2	$570K	Sell	18,092 -59,475	-77%	-$2.08M	0.07%	84
2022 Q1	$3.56M	Buy	77,567 +2,357	+3%	+$112K	0.38%	54
2021 Q4	$3.82M	Buy	75,210 +2,380	+3%	+$165K	0.38%	53
2021 Q3	$5.39M	Buy	72,830 +68,667	+1,649%	+$5.76M	0.56%	44
2021 Q2	$344K	Buy	4,163 +1,146	+38%	+$97.4K	0.04%	96
2021 Q1	$252K	Buy	3,017 +800	+36%	+$79.4K	0.03%	102
2020 Q4	$241K	Buy	+2,217	New	+$177K	0.03%	96

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

SP Asset Management's ARKG Position: Q1 2023 in Review

SP Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 15,667 shares — an estimated $442K sold.

SP Asset Management first reported a position in ARKG in Q4 2020 and held it in 9 quarters. The position peaked at $5.39M in Q3 2021. 296 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

SP Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
SP Asset Management sold 15,667 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $442K.
SP Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 9 quarters.
SP Asset Management's ARK Genomic Revolution ETF position peaked at $5.39M in Q3 2021.
296 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on SP Asset Management's 13F filing for Q1 2023, filed 5 May 2023.